Dabigatran Reversal Agent – Idarucizumab
Thanks to Rob MacSweeney‘s fantastic Critical Care Reviews I learned of Idarucizumab, a monoclonal antibody fragment that binds the (pesky) […]
Acute Med, All Updates, ICU, Resus, Trauma
drugs
Acute Med, All Updates, ICU, PHARM, Resus
Esmolol for refractory VF
Already well publicised on social media, the team at Hennepin County published a retrospective comparison between patients with refractory VF […]
All Updates, ICU, Kids, PHARM, Resus
Atropine for Paediatric RSI?
Image: Atropine injection ampoule by Skirtick, CC BY-SA 4.0, via Wikimedia Commons In some areas it has been traditional to […]
Acute Med, All Updates, ICU, Resus
Beta blockers potentially beneficial in septic shock
Counterintuitive as it sounds, this is pretty cool. I blogged about these guys before when they published their findings on […]
Acute Med, All Updates, ICU, Resus
Beta blockade in sepsis
What do septic patients need if they remain shocked after fluid resuscitation? Catecholamines right? Let’s stimulate some adrenoceptors and support […]
All Updates, ICU
Xenon – no bull?
Xenon, an inert ‘noble’ gas with proven anaesthetic properties, has possible neuroprotective properties and appears to be also cardioprotective in […]
Acute Med, All Updates, ICU, PHARM, Resus
Clopidogrel and aspirin for TIA
A large Chinese trial compared aspirin alone with combination aspirin / clopidogrel in patients who had had a TIA in […]
Acute Med, All Updates, PHARM, Resus
5 days of steroids for COPD exacerbation
A randomised trial showed 5 days of oral steroid therapy (40 mg prednisone) was non-inferior to 14 days’ duration in […]
Acute Med, All Updates, ICU, Resus
Potential new therapy for acute heart failure
Interesting new drug to know about: Serelaxin, recombinant human relaxin-2. It’s hard to assess the clinical significance of the statistically […]
Acute Med, All Updates, PHARM, Resus
Stroke thrombolysis outcomes from registry
Data from a large national stroke registry are reported to show that in patients who received tPA, outcomes were worse […]